journal article·2023-09Open access

Cerebral Microvascular Injury Induced by Lag3‐Dependent α‐Synuclein Fibril Endocytosis Exacerbates Cognitive Impairment in a Mouse Model of α‐Synucleinopathies

Qingxi Zhang, Qingrui Duan, Yuyuan Gao, Peikun He, Rui Huang, Haifeng Huang, Yanyi Li, Guixian Ma, Yuhu Zhang, Kun Nie, Lijuan Wang

Advanced Science· Volume 10· Issue 25

Abstract

Abstract The pathological accumulation of α‐synuclein (α‐Syn) and the transmission of misfolded α‐Syn underlie α‐synucleinopathies. Increased plasma α‐Syn levels are associated with cognitive impairment in Parkinson's disease, multiple system atrophy, and dementia with Lewy bodies, but it is still unknown whether the cognitive deficits in α‐synucleinopathies have a common vascular pathological origin. Here, it is reported that combined injection of α‐Syn preformed fibrils (PFFs) in the unilateral substantia nigra pars compacta, hippocampus, and cerebral cortex results in impaired spatial learning and memory abilities at 6 months post‐injection and that this cognitive decline is related to cerebral microvascular injury. Moreover, insoluble α‐Syn inclusions are found to form in primary mouse brain microvascular endothelial cells (BMVECs) through lymphocyte‐activation gene 3 (Lag3)‐dependent α‐Syn PFFs endocytosis, causing poly(ADP‐ribose)‐driven cell death and reducing the expression of tight junction proteins in BMVECs. Knockout of Lag3 in vitro prevents α‐Syn PFFs from entering BMVECs, thereby reducing the abovementioned response induced by α‐Syn PFFs. Deletion of endothelial cell‐specific Lag3 in vivo reverses the negative effects of α‐Syn PFFs on cerebral microvessels and cognitive function. In short, this study reveals the effectiveness of targeting Lag3 to block the spread of α‐Syn fibrils to endothelial cells in order to improve cognition.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Parkinson's Disease Mechanisms and Treatments · Alzheimer's disease research and treatments · Botulinum Toxin and Related Neurological Disorders

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Neurology Guangdong Neuroscience Institute Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences) Southern Medical University Guangzhou 510080 China

Guangdong Cardiovascular Institute Guangdong Provincial People's Hospital Guangdong Academy of Medical Sciences Guangzhou 510100 China

Guangzhou Key Laboratory of Diagnosis and Treatment for Neurodegenerative Diseases Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences) Southern Medical University Guangzhou 510080 China

Funding

National Natural Science Foundation of China · China Postdoctoral Science Foundation · Science and Technology Planning Project of Guangdong Province · Guangdong Medical Research Foundation

References (89)

Show source-provided references
1. 10.1002/mds.1055710.1002/mds.10557 ↗
2. 10.1038/ncomms357510.1038/ncomms3575 ↗
3. 10.1038/s41467-019-13564-w10.1038/s41467-019-13564-w ↗
4. 10.1038/s41467-019-14189-910.1038/s41467-019-14189-9 ↗
5. 10.1016/j.parkreldis.2017.05.02210.1016/j.parkreldis.2017.05.022 ↗
6. 10.1523/JNEUROSCI.0234-12.201210.1523/JNEUROSCI.0234-12.2012 ↗
7. Ferreira D. G. · Cereb. Cortex · 2017 · 27 · 718
8. 10.1016/j.bbi.2018.02.01210.1016/j.bbi.2018.02.012 ↗
9. 10.1038/nn.464810.1038/nn.4648 ↗
10. 10.1002/mds.2669810.1002/mds.26698 ↗
11. 10.1177/0271678X1668891910.1177/0271678X16688919 ↗
12. 10.1136/jnnp-2016-31485710.1136/jnnp-2016-314857 ↗
13. 10.1136/jnnp-2017-31582110.1136/jnnp-2017-315821 ↗
14. 10.1016/j.nbd.2018.04.01510.1016/j.nbd.2018.04.015 ↗
15. 10.1002/mds.2568810.1002/mds.25688 ↗
16. 10.3233/JAD-19056710.3233/JAD-190567 ↗
17. 10.1038/nature1454710.1038/nature14547 ↗
18. 10.1007/s00401-019-02037-510.1007/s00401-019-02037-5 ↗
19. 10.1038/nprot.2014.14310.1038/nprot.2014.143 ↗
20. 10.1016/j.nbd.2017.05.01410.1016/j.nbd.2017.05.014 ↗
21. 10.1186/s40478-018-0537-x10.1186/s40478-018-0537-x ↗
22. 10.1186/s13024-018-0257-510.1186/s13024-018-0257-5 ↗
23. 10.1016/j.neuron.2011.08.03310.1016/j.neuron.2011.08.033 ↗
24. 10.1126/science.aat840710.1126/science.aat8407 ↗
25. 10.1007/s12035-022-03119-410.1007/s12035-022-03119-4 ↗
26. 10.1111/jnc.1362710.1111/jnc.13627 ↗
27. 10.1038/nrn.2017.7510.1038/nrn.2017.75 ↗
28. 10.1073/pnas.190911011710.1073/pnas.1909110117 ↗
29. 10.1084/jem.2011245710.1084/jem.20112457 ↗
30. 10.1126/science.122715710.1126/science.1227157 ↗
31. 10.1016/j.nbd.2015.06.00310.1016/j.nbd.2015.06.003 ↗
32. 10.1186/s40478-017-0416-x10.1186/s40478-017-0416-x ↗
33. 10.1073/pnas.171044211410.1073/pnas.1710442114 ↗
34. 10.1016/j.bbr.2017.05.06110.1016/j.bbr.2017.05.061 ↗
35. Haase D. · ALTEX · 2015 · 32 · 307
36. 10.1161/CIRCULATIONAHA.108.84678210.1161/CIRCULATIONAHA.108.846782 ↗
37. 10.1126/sciadv.140024410.1126/sciadv.1400244 ↗
38. 10.1111/acel.1358110.1111/acel.13581 ↗
39. 10.1111/epi.1718610.1111/epi.17186 ↗
40. 10.1002/ana.2374610.1002/ana.23746 ↗
41. 10.1523/JNEUROSCI.1871-20.202010.1523/JNEUROSCI.1871-20.2020 ↗
42. 10.1073/pnas.211348911910.1073/pnas.2113489119 ↗
43. 10.1038/s41467-021-23682-z10.1038/s41467-021-23682-z ↗
44. Sántha P. · Front. Mol. Neurosci. · 2015 · 8 · 88
45. 10.1016/j.neubiorev.2017.04.00310.1016/j.neubiorev.2017.04.003 ↗
46. 10.1146/annurev-neuro-071714-03383510.1146/annurev-neuro-071714-033835 ↗
47. 10.1038/nn.420110.1038/nn.4201 ↗
48. 10.1111/nan.1237510.1111/nan.12375 ↗
49. 10.1038/s41591-018-0297-y10.1038/s41591-018-0297-y ↗
50. 10.3389/fncel.2014.0021110.3389/fncel.2014.00211 ↗
51. 10.1371/journal.pone.027765810.1371/journal.pone.0277658 ↗
52. 10.1016/j.trsl.2007.03.01310.1016/j.trsl.2007.03.013 ↗
53. 10.1007/s00401-017-1746-210.1007/s00401-017-1746-2 ↗
54. 10.1016/j.ymeth.2015.03.01110.1016/j.ymeth.2015.03.011 ↗
55. 10.1126/science.aah337410.1126/science.aah3374 ↗
56. Nielsen S. S. E. · J. Visualized Exp. · 2017 · 127
57. 10.1007/s12035-021-02421-x10.1007/s12035-021-02421-x ↗
58. 10.1038/nrc252310.1038/nrc2523 ↗
59. 10.1111/bph.1374810.1111/bph.13748 ↗
60. 10.1101/gad.133180510.1101/gad.1331805 ↗
61. 10.1126/science.808050010.1126/science.8080500 ↗
62. 10.7150/jca.4005510.7150/jca.40055 ↗
63. 10.14336/AD.2017.052010.14336/AD.2017.0520 ↗
64. 10.1038/s41591-019-0440-410.1038/s41591-019-0440-4 ↗
65. 10.1186/1750-1326-8-4410.1186/1750-1326-8-44 ↗
66. 10.1016/j.expneurol.2016.09.00310.1016/j.expneurol.2016.09.003 ↗
67. 10.3233/JAD-14309010.3233/JAD-143090 ↗
68. 10.1016/j.exger.2023.11219810.1016/j.exger.2023.112198 ↗
69. 10.3233/JAD-15097910.3233/JAD-150979 ↗
70. 10.1038/s41586-018-0790-y10.1038/s41586-018-0790-y ↗
71. 10.1007/s00401-017-1787-610.1007/s00401-017-1787-6 ↗
72. 10.1016/S0304-3940(02)00297-510.1016/S0304-3940(02)00297-5 ↗
73. 10.1007/s00401-016-1542-410.1007/s00401-016-1542-4 ↗
74. 10.1007/s00401-016-1660-z10.1007/s00401-016-1660-z ↗
75. 10.3390/ijms23231529410.3390/ijms232315294 ↗
76. 10.1016/j.peptides.2014.09.01810.1016/j.peptides.2014.09.018 ↗
77. 10.3233/JPD-17124810.3233/JPD-171248 ↗
78. 10.1126/science.276.5321.204510.1126/science.276.5321.2045 ↗
79. 10.4049/jimmunol.170108010.4049/jimmunol.1701080 ↗
80. 10.5966/sctm.2016-007110.5966/sctm.2016-0071 ↗
81. 10.1016/S0165-0270(96)02211-X10.1016/S0165-0270(96)02211-X ↗
82. 10.1016/j.yebeh.2019.10654710.1016/j.yebeh.2019.106547 ↗
83. 10.1007/s00401-019-02023-x10.1007/s00401-019-02023-x ↗
84. 10.1038/nbt89610.1038/nbt896 ↗
85. 10.1016/S0006-3495(04)74307-610.1016/S0006-3495(04)74307-6 ↗
86. 10.1093/brain/awv31310.1093/brain/awv313 ↗
87. 10.3390/v1010056310.3390/v10100563 ↗
88. 10.3390/ijms1808178310.3390/ijms18081783 ↗
89. 10.3758/BF0319314610.3758/BF03193146 ↗